WHO vaccine-preventable diseases: monitoring system. 2014 global summary

Last updated 15-Jul-2014 (Data received as of 8-Jul-2014)
Next overall update Fall 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4601 Infant (under 12 months) mortality rate: 652
GDP / capita (US$): 1'2551 Child (under 5 years) mortality rate: 1012

Population data in thousands3

  2013  2012  2011  2010  2009  2000  1990  1980 
Total population 11'745  11'451  11'162  10'876  10'593  8'746  6'020  4'495 
Births 434  428  422  416  410  369  287  215 
Surviving infants 402  396  390  384  377  330  248  180 
Pop. less than 5 years 1'886  1'856  1'823  1'784  1'748  1'511  1'076  776 
Pop. less than 15 years 4'970  4'870  4'766  4'659  4'560  3'851  2'638  1'875 
Female 15-49 years 2'741  2'662  2'586  2'513  2'439  1'983  1'359  1'057 

Number of reported case

(Click for retrospective incidence data for Guinea)
Diphtheria 37 
Japanese encephalitis
Measles 53  11  45  264  11'294  12'756  8'552 
Mumps
Pertussis 25  247  412  2'315 
Polio* 43  155  32 
Rubella 10  55  34 
Rubella (CRS)
Tetanus (neonatal) 51  17  64  21  245  53 
Tetanus (total) 51  64  54  245  524  482 
Yellow fever 445 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Guinea)
Vaccine year result method % card seen                                                
BCG 2011  82  DHS/MICS   44  95  84  93  93  93  71  50 
DTP1 2011  76  DHS/MICS   44  95  99*  80  95  89  67 
DTP3 2011  50  DHS/MICS   44  90  99*  85  90  85  57  20 
HepB_BD         
HepB3 2011  50  DHS/MICS   44  90  99*  85  90  85 
Hib3 2011  50  DHS/MICS   44  90  99*  85  90  85 
JapEnc         
MCV 2011  62  DHS/MICS   44  90  99*  90  90  87  59  25 
MCV2         
PCV1         
PCV3         
Pol3 2011  51  DHS/MICS   44  90  97  85  90  90  57  20 
Rota1         
Rota_last         
Rubella1         
TT2plus 2011  71  DHS/MICS   44  93  86  80  70  82  43  21 
PAB         
VAD1          80  100  90  97 
YFV 2011  38  DHS/MICS   44  90  99*  90  90  71 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Guinea)
BCG 66  66  82  93  91  81  50 
DTP1 76  76  76  86  76  61  40 
DTP3 63  63  63  64  57  46  17 
HepB3 63  63  63  64  57 
HepB_BD
Hib3 63  63  63  64  57 
MCV 62  62  62  58  53  42  35 
MCV2
PAB 80  80  80  90  96  79  27 
PCV3
Pol3 64  64  63  62  60  47  18 
Rota_last
YFV 63  63  63  56  52 

Number of districts in the country 38  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 79
From 80 to 89% 13
From 50 to 79% 8
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2013 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
TT 1st contact; +1, +6 months; +1, +1 year; Yes
VitaminA 6, 12 months; Yes 6-59 months
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2013  2012  2011  2010  2009  2008  2007 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011- 2015  2007-2011  2007-2011  2007-2011  2007-2011 
Nº of districts with microplans that include activities to raise immunization coverage number 38  38  38  38  38  38  38 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No       

System performance

Total Nº districts in country number 38  38  38  38  38  38  38 
Nº districts with DTP3 coverage >=80% number 35  37  33  27  24  25  19 
% of districts with DTP3 coverage >=80% From 0 to 100% 92  97  87  71  63  66  50 
Nº districts with measles (MCV1) coverage >=95% number 23  18  21  10   
% of districts with MCV1 coverage >=95% From 0 to 100% 61  47  55  26  16  18   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes       
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Estimated percentage of routine vaccines funded by Government From 0 to 100% 41  24  24  30  65  70 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.